138 related articles for article (PubMed ID: 19381801)
21. Somatic mutations in benign breast disease tissue and risk of subsequent invasive breast cancer.
Rohan TE; Miller CA; Li T; Wang Y; Loudig O; Ginsberg M; Glass A; Mardis E
Br J Cancer; 2018 Jun; 118(12):1662-1664. PubMed ID: 29872146
[TBL] [Abstract][Full Text] [Related]
22. Expression of cytochrome P450 1B1 and catechol-O-methyltransferase in breast tissue and their associations with breast cancer risk.
Wen W; Ren Z; Shu XO; Cai Q; Ye C; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):917-20. PubMed ID: 17507616
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians.
Chakraborty A; Mishra AK; Soni A; Regina T; Mohil R; Bhatnagar D; Bhatnagar A; Chintamani C; Sharma PC; Saxena S
Cancer Detect Prev; 2009; 32(5-6):386-94. PubMed ID: 19588543
[TBL] [Abstract][Full Text] [Related]
24. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ
Cancer; 2006 Sep; 107(6):1240-7. PubMed ID: 16902983
[TBL] [Abstract][Full Text] [Related]
25. Concomitant presence of mutations in mitochondrial genome and p53 in cancer development - a study in north Indian sporadic breast and esophageal cancer patients.
Gochhait S; Bhatt A; Sharma S; Singh YP; Gupta P; Bamezai RN
Int J Cancer; 2008 Dec; 123(11):2580-6. PubMed ID: 18792899
[TBL] [Abstract][Full Text] [Related]
26. Molecular epidemiologic studies of polycyclic aromatic hydrocarbon-DNA adducts and breast cancer.
Rundle A; Tang D; Hibshoosh H; Schnabel F; Kelly A; Levine R; Zhou J; Link B; Perera F
Environ Mol Mutagen; 2002; 39(2-3):201-7. PubMed ID: 11921190
[TBL] [Abstract][Full Text] [Related]
27. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
[TBL] [Abstract][Full Text] [Related]
28. Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients.
Yu M; Zhou Y; Shi Y; Ning L; Yang Y; Wei X; Zhang N; Hao X; Niu R
IUBMB Life; 2007 Jul; 59(7):450-7. PubMed ID: 17654121
[TBL] [Abstract][Full Text] [Related]
29. Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma.
Pejovic T; Ladner D; Intengan M; Zheng K; Fairchild T; Dillon D; Easley S; Dillon D; Marchetti D; Schwartz P; Lele S; Costa J; Odunsi K
Eur J Cancer; 2004 Nov; 40(16):2519-24. PubMed ID: 15519528
[TBL] [Abstract][Full Text] [Related]
30. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
Xie D; Shu XO; Deng Z; Wen WQ; Creek KE; Dai Q; Gao YT; Jin F; Zheng W
J Natl Cancer Inst; 2000 Mar; 92(5):412-7. PubMed ID: 10699071
[TBL] [Abstract][Full Text] [Related]
31. Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study.
Tang D; Rundle A; Mooney L; Cho S; Schnabel F; Estabrook A; Kelly A; Levine R; Hibshoosh H; Perera F
Breast Cancer Res Treat; 2003 Mar; 78(2):217-22. PubMed ID: 12725421
[TBL] [Abstract][Full Text] [Related]
32. Sequence variations of mitochondrial DNA D-loop region are highly frequent events in familial breast cancer.
Yu M; Shi Y; Zhang F; Zhou Y; Yang Y; Wei X; Zhang L; Niu R
J Biomed Sci; 2008 Jul; 15(4):535-43. PubMed ID: 18157618
[TBL] [Abstract][Full Text] [Related]
33. Alcohol consumption and breast tumor mitochondrial DNA mutations.
Platek ME; Shields PG; Tan D; Marian C; Bonner MR; McCann SE; Nie J; Wilding GE; Ambrosone C; Millen AE; Trevisan M; Russell M; Nochajski TH; Edge SB; Winston J; Freudenheim JL
Breast Cancer Res Treat; 2010 Jun; 121(2):453-60. PubMed ID: 19847642
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial DNA mutations---candidate biomarkers for breast cancer diagnosis in Bangladesh.
Sultana GN; Rahman A; Shahinuzzaman AD; Begum RA; Hossain CF
Chin J Cancer; 2012 Sep; 31(9):449-54. PubMed ID: 22692071
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial complex I and V gene polymorphisms associated with breast cancer in mizo-mongloid population.
Thapa S; Lalrohlui F; Ghatak S; Zohmingthanga J; Lallawmzuali D; Pautu JL; Senthil Kumar N
Breast Cancer; 2016 Jul; 23(4):607-16. PubMed ID: 25896597
[TBL] [Abstract][Full Text] [Related]
36. History of benign breast disease and risk of breast cancer among women in China: a case-control study.
Dorjgochoo T; Deming SL; Gao YT; Lu W; Zheng Y; Ruan Z; Zheng W; Shu XO
Cancer Causes Control; 2008 Oct; 19(8):819-28. PubMed ID: 18347922
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of breast tumor pathogenesis and somatic mutations on the basis of mitochondrial DNA whole genome].
Yang Y; He JD; Guo XJ; Che YH; Zhang Y; Li L
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(14):973-6. PubMed ID: 21609549
[TBL] [Abstract][Full Text] [Related]
38. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
39. Mutation screening in the mitochondrial D-loop region of tumoral and non-tumoral breast cancer in Iranian patients.
Rahmani B; Azimi C; Omranipour R; Raoofian R; Zendehdel K; Saee-Rad S; Heidari M
Acta Med Iran; 2012; 50(7):447-53. PubMed ID: 22930374
[TBL] [Abstract][Full Text] [Related]
40. [Roles of mitochondrial DNA somatic mutations in the pathogenesis of benign breast disease: a perspective from whole genome study].
Yang Y; Mei S; He JD; Guo XJ; Che YH; Zhang Y; Li L
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2394-7. PubMed ID: 23158660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
